Michael Seggev has over 30 years of experience in healthcare and biopharma. He has worked on vaccines for infectious diseases including Hepatitis B, HPV and HIV. He was at Merck for 22 years, serving as a commercial lead in the HIV Vaccine development group and then leading the team behind the company’s launch of a first-in-class antiretroviral medication to treat HIV/AIDS. He then served as a consultant to the International AIDS Vaccine Initiative, and most recently worked in Teva Pharmaceuticals’ Digital Health group before joining Vocalis Health, a company pioneering AI-based vocal biomarkers for use in healthcare, as its Chief Commercial Officer.
Covid vaccines are the talk of the town but in the meantime, there remains a great need for Covid-19 management solutions – including effective screening, efficient testing, improving treatments, battling vaccine misinformation, continued mask-wearing and social distancing – to protect the public.